Suppr超能文献

非交联马胶原(Salvecoll-E 凝胶)治疗复杂性肛直肠瘘。

Non cross-linked equine collagen (Salvecoll-E gel) for treatment of complex ano-rectal fistula.

机构信息

University of Milano-Bicocca, General Surgery Department, Istituti Clinici Zucchi-Monza, Italy.

University of Milano-Bicocca, General Surgery Department, Istituti Clinici Zucchi-Monza, Italy.

出版信息

Asian J Surg. 2020 Feb;43(2):401-404. doi: 10.1016/j.asjsur.2019.06.009. Epub 2019 Jul 15.

Abstract

BACKGROUND

Fistula-in-ano is one of the most commonly presenting anorectal diseases. Sphincter sparing treatment options should be considered in patients with complex fistulas. Salvecoll-E gel is a native collagen deantigenated and purified, non-cross-linked equine dermal extract, with an amino acid composition identical to human collagen.

METHODS

The multicentric trial study was a prospective, single-arm observational clinical study with the objective to assess the efficacy of Salvecoll-E gel for anal fistula repair in 70 patients. All patients had undergone preliminary surgical treatment consisting of positioning of a draining loosing seton that was maintained for a period of 4-6 weeks. After seton removal, a gentle debridement and washing of the fistula track was performed. The scar tissue was removed from the internal orifice. Internal opening was covered by a side-to side mucosal suture. Salvecoll-E was injected through the external opening into the fistula track, the external opening it has been opened.

RESULTS

Twelve months after surgery, 55 patients demonstrated a clinically healed fistula (78,5%), 15 patients have a recurrence (21,5%). Most of the recurrences were observed in the first 6 months of treatment (13/15, 86.6%). We don't observe any worsening in CCF score. The results obtained at 1 year certainly seem satisfactory and in line with the best results published in literature using mini-invasive techniques.

CONCLUSION

Salvecoll-E gel is a promising non-invasive technique for conservative treatment of anal fistulas, it's well tolerated by the patients and, in case of recurrence, reinjection or all other known techniques are feasible.

摘要

背景

肛瘘是最常见的肛肠疾病之一。对于复杂肛瘘患者,应考虑保留括约肌的治疗方案。Salvecoll-E 凝胶是一种去抗原化和纯化的、非交联的马真皮提取物,其氨基酸组成与人体胶原蛋白相同。

方法

这项多中心试验研究是一项前瞻性、单臂观察性临床研究,目的是评估 Salvecoll-E 凝胶在 70 例肛瘘修复中的疗效。所有患者均接受了初步的手术治疗,包括放置引流松解缝线,维持 4-6 周。缝线取出后,轻轻清创并冲洗瘘管。从内口去除瘢痕组织。内口用侧侧黏膜缝合覆盖。Salvecoll-E 通过外口注入瘘管,外口已开放。

结果

术后 12 个月,55 例患者临床治愈(78.5%),15 例患者复发(21.5%)。大多数复发发生在治疗的前 6 个月(13/15,86.6%)。我们没有观察到 CCF 评分的恶化。1 年的结果似乎令人满意,与文献中使用微创技术报道的最佳结果一致。

结论

Salvecoll-E 凝胶是一种有前途的非侵入性技术,可用于保守治疗肛瘘,患者耐受性良好,在复发的情况下,可再次注射或采用其他已知技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验